Sepsis Diagnostic Market by Testing Type, Technology, Product, Method, Pathogen, End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation

Description

List of Tables

The Global Sepsis Diagnostic Market is forecasted to grow significantly, with a projected USD 556.86 million in 2023 at a CAGR of 9.96% and expected to reach a staggering USD 1,084.17 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Sepsis Diagnostic Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Sepsis Diagnostic Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Testing Type, market is studied across Laboratory Testing and PoC Testing. The Laboratory Testing commanded largest market share of 76.43% in 2022, followed by PoC Testing.

Based on Technology, market is studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics. The Microbiology commanded largest market share of 32.78% in 2022, followed by Molecular Diagnostics.

Based on Product, market is studied across Assay Kits and Reagents, Blood Culture Media, Instruments, and Software. The Blood Culture Media commanded largest market share of 37.11% in 2022, followed by Assay Kits and Reagents.

Based on Method, market is studied across Automated Diagnostics and Conventional Diagnostics. The Conventional Diagnostics commanded largest market share of 69.37% in 2022, followed by Automated Diagnostics.

Based on Pathogen, market is studied across Bacterial Sepsis and Fungal Sepsis. The Bacterial Sepsis is further studied across Gram-Negative Bacteria and Gram-Positive Bacteria. The Fungal Sepsis commanded largest market share of 64.79% in 2022, followed by Bacterial Sepsis.

Based on End-user, market is studied across Hospitals, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. The Hospitals commanded largest market share of 48.17% in 2022, followed by Pathology & Reference Laboratories.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 42.40% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Sepsis Diagnostic Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Sepsis Diagnostic Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Sepsis Diagnostic Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Sepsis Diagnostic Market?

4. What is the competitive strategic window for opportunities in the Global Sepsis Diagnostic Market?

5. What are the technology trends and regulatory frameworks in the Global Sepsis Diagnostic Market?

6. What is the market share of the leading vendors in the Global Sepsis Diagnostic Market?

7. What modes and strategic moves are considered suitable for entering the Global Sepsis Diagnostic Market?

Product Code: MRR-A339DAEFABB5

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Sepsis Diagnostic Market, by Testing Type, 2022 vs 2030
4.3. Sepsis Diagnostic Market, by Technology, 2022 vs 2030
4.4. Sepsis Diagnostic Market, by Product, 2022 vs 2030
4.5. Sepsis Diagnostic Market, by Method, 2022 vs 2030
4.6. Sepsis Diagnostic Market, by Pathogen, 2022 vs 2030
4.7. Sepsis Diagnostic Market, by End-user, 2022 vs 2030
4.8. Sepsis Diagnostic Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing Incidence and Prevalence of Sepsis
  - 5.1.1.2. Growing Occurrence of Hospital Derived Infections
  - 5.1.1.3. Development of Technology Advanced Diagnostic Solutions
- 5.1.2. Restraints
  - 5.1.2.1. Capital Intensive Automated Diagnostic Services and Dearth of Reimbursement Situations
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging Development of Rapid Diagnostics Globally
  - 5.1.3.2. Development of Novel Biomarkers for Sepsis Diagnostics
- 5.1.4. Challenges
  - 5.1.4.1. Lack of Awareness and Standard Protocols for the Procedure
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Sepsis Diagnostic Market, by Testing Type

6.1. Introduction
6.2. Laboratory Testing
6.3. PoC Testing

7. Sepsis Diagnostic Market, by Technology

7.1. Introduction
7.2. Flow Cytometry
7.3. Immunoassays
7.4. Microbiology
7.5. Molecular Diagnostics

8. Sepsis Diagnostic Market, by Product

8.1. Introduction
8.2. Assay Kits and Reagents
8.3. Blood Culture Media
8.4. Instruments
8.5. Software

9. Sepsis Diagnostic Market, by Method

9.1. Introduction
9.2. Automated Diagnostics
9.3. Conventional Diagnostics

10. Sepsis Diagnostic Market, by Pathogen

10.1. Introduction
10.2. Bacterial Sepsis
- 10.2.1. Gram-Negative Bacteria
- 10.2.2. Gram-Positive Bacteria
10.3. Fungal Sepsis

11. Sepsis Diagnostic Market, by End-user

11.1. Introduction
11.2. Hospitals
11.3. Pathology & Reference Laboratories
11.4. Research Laboratories & Academic Institutes

12. Americas Sepsis Diagnostic Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Sepsis Diagnostic Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Sepsis Diagnostic Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player

16. List of Company Mentioned

17. Appendix

17.1. Discussion Guide
17.2. License & Pricing